ALEAF (Aleafia Health) EBIT: $-18.51 Mil (TTM As of Mar. 2023)


ALEAF Aleafia Health Inc ALEAF
12 GF Score
Price $0.00
View Full Analysis

What is Aleafia Health EBIT?

Aleafia Health ALEAF -99.00% 12 EBIT is $-18.51 Mil as of Mar. 2023. GuruFocus rates ALEAF with a GF Score™ of 12/100.

Aleafia Health's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2023 was $-7.12 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2023 was $-18.51 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Aleafia Health's annualized ROC % for the quarter that ended in Mar. 2023 was -64.48%. Aleafia Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2023 was -101.00%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Aleafia Health  (GREY:ALEAF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Aleafia Health's annualized ROC % for the quarter that ended in Mar. 2023 is calculated as:

ROC % (Q: Mar. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2022 ) + Invested Capital (Q: Mar. 2023 ))/ count )
=-21.524 * ( 1 - 0% )/( (36.15 + 30.609)/ 2 )
=-21.524/33.3795
=-64.48 %

where

Invested Capital(Q: Dec. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=50.874 - 14.368 - ( 0.356 - max(0, 27.663 - 32.54+0.356))
=36.15

Invested Capital(Q: Mar. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=43.795 - 13.035 - ( 0.391 - max(0, 26.048 - 26.199+0.391))
=30.609

Note: The Operating Income data used here is four times the quarterly (Mar. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Aleafia Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2022  Q: Mar. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-28.472/( ( (16.571 + max(14.595, 0)) + (15.849 + max(9.365, 0)) )/ 2 )
=-28.472/( ( 31.166 + 25.214 )/ 2 )
=-28.472/28.19
=-101.00 %

where Working Capital is:

Working Capital(Q: Dec. 2022 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4.138 + 17.116 + 10.93) - (14.368 + 0 + 3.221)
=14.595

Working Capital(Q: Mar. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.935 + 13.892 + 8.981) - (13.035 + 0 + 3.408)
=9.365

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Aleafia Health's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2023 )
=-18.509/0.000
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aleafia Health EBIT Related Terms

Aleafia Health EBIT Historical Data

* Premium members only.

The historical data trend for Aleafia Health's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aleafia Health EBIT Chart

Aleafia Health Annual Data
Trend Jan12 Jan13 Jan14 Jan15 Jan16 Oct17 Dec18 Dec19 Dec20 Mar23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.71 -14.54 -18.21 -192.37 -18.45

Aleafia Health Quarterly Data
Oct17 Jan18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Jun22 Sep22 Dec22 Mar23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -66.13 -1.34 6.80 -16.85 -7.12

ALEAF vs ZTS, CTLT, VTRS: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Aleafia Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aleafia Health EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aleafia Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Aleafia Health's EV-to-EBIT falls into.


ALEAF
12GF Score
Aleafia Health Inc ALEAF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aleafia Health EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-18.51 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-18.51 Mil mean?
Aleafia Health (ALEAF) has a EBIT of $-18.51 Mil as of Mar. 2023. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Aleafia Health.
Is Aleafia Health's EBIT too high?
Aleafia Health's current EBIT is $-18.51 Mil. Overall, Aleafia Health has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Aleafia Health's EBIT compare to ZTS and CTLT?
Aleafia Health's EBIT of $-18.51 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Aleafia Health. Aleafia Health's current EBIT is $-18.51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aleafia Health stock overvalued right now?
Aleafia Health (ALEAF) has a current EBIT of $-18.51 Mil. The current EBIT is $-18.51 Mil. Aleafia Health's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Aleafia Health (ALEAF), the current EBIT is $-18.51 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aleafia Health Business Description

Address 85 Basaltic Road, Concord, ON, CAN, L4K 1G4
Aleafia Health Inc is a vertically integrated cannabis health and wellness company which owns three cannabis product and cultivation facilities where it produces a diverse portfolio of commercially high-margin derivative products including oils, capsules and sprays.
12GF Score

Get the complete analysis for ALEAF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price